Smith Shellnut Wilson LLC Abbott Laboratories Transaction History

Smith Shellnut Wilson LLC

$203 Million
Q2 2024

A detailed history of Smith Shellnut Wilson LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Smith Shellnut Wilson LLC holds 4,813 shares of ABT stock, worth $540,981. This represents 0.25% of its overall portfolio holdings.

Number of Shares

4,813

Previous 4,813 -0.0%

Holding current value

$540,981

Previous $547,000 8.59%

% of portfolio

0.25%

Previous 0.29%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$109.52 - $120.96 $38,660 - $42,698	-353 Reduced 6.83%	4,813 $547,000
Q4 2023 Feb 21, 2024	SELL	$90.19 - $110.4 $60,788 - $74,409	-674 Reduced 11.54%	5,166 $568,000
Q2 2023 Aug 04, 2023	SELL	$100.78 - $112.29 $1,914 - $2,133	-19 Reduced 0.32%	5,840 $636,000
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $1,330 - $1,561	-14 Reduced 0.24%	5,859 $643,000
Q3 2022 Nov 03, 2022	BUY	$96.76 - $112.03 $17,126 - $19,829	177 Added 3.11%	5,873 $568,000
Q2 2022 Aug 02, 2022	SELL	$102.07 - $123.37 $35,724 - $43,179	-350 Reduced 5.79%	5,696 $619,000
Q1 2022 May 02, 2022	SELL	$114.02 - $139.04 $3,420 - $4,171	-30 Reduced 0.49%	6,046 $716,000
Q4 2021 Feb 03, 2022	BUY	$115.53 - $141.46 $7,856 - $9,619	68 Added 1.13%	6,076 $855,000
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $2,449 - $2,710	21 Added 0.35%	6,008 $709,000
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $33,323 - $39,226	-315 Reduced 5.0%	5,987 $694,000
Q1 2021 Apr 06, 2021	BUY	$108.84 - $128.23 $1,414 - $1,666	13 Added 0.21%	6,302 $755,000
Q4 2020 Feb 05, 2021	SELL	$105.0 - $114.42 $75,495 - $82,267	-719 Reduced 10.26%	6,289 $689,000
Q1 2020 Apr 20, 2020	BUY	$62.82 - $91.86 $7,538 - $11,023	120 Added 1.74%	7,008 $553,000
Q4 2019 Feb 05, 2020	BUY	$78.51 - $87.4 $177,982 - $198,135	2,267 Added 49.06%	6,888 $598,000
Q3 2019 Nov 06, 2019	BUY	$81.84 - $88.74 $16,286 - $17,659	199 Added 4.5%	4,621 $387,000
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $4,955 - $5,780	68 Added 1.56%	4,422 $372,000
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $3,642 - $4,403	55 Added 1.28%	4,354 $348,000
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $3,605 - $4,084	-55 Reduced 1.26%	4,299 $311,000
Q1 2018 Apr 24, 2018	SELL	$56.27 - $63.62 $66,286 - $74,944	-1,178 Reduced 21.29%	4,354 $261,000
Q4 2017 Feb 22, 2018	BUY	$53.68 - $57.47 $11,648 - $12,470	217 Added 4.08%	5,532 $316,000
Q3 2017 Nov 17, 2017	BUY	$48.06 - $53.64 $255,438 - $285,096	5,315	5,315 $284,000

Others Institutions Holding ABT

# of Institutions

3,135

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith Shellnut Wilson LLC , based on Form 13F filings with the SEC.

News

Stay updated on Smith Shellnut Wilson LLC with notifications on news.

Account

Smith Shellnut Wilson LLC Abbott Laboratories Transaction History